11418 related articles for article (PubMed ID: 10868490)
1. Advances in management of melanoma.
Hersey P
Aust N Z J Med; 1999 Jun; 29(3):292-9. PubMed ID: 10868490
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in the care of the patient with malignant melanoma.
Reintgen D; Balch CM; Kirkwood J; Ross M
Ann Surg; 1997 Jan; 225(1):1-14. PubMed ID: 8998115
[TBL] [Abstract][Full Text] [Related]
3. Review of sentinel lymph node biopsy and systemic interferon for melanoma: promising but investigational modalities.
Otley CC; Zitelli JA
Dermatol Surg; 2000 Mar; 26(3):177-80. PubMed ID: 10759789
[TBL] [Abstract][Full Text] [Related]
4. Lymphatic mapping and sentinel node biopsy in patients with malignant melanoma.
Reintgen D; Rapaport D; Tanabe KK; Ross M
J Fla Med Assoc; 1997 Mar; 84(3):188-93. PubMed ID: 9143171
[TBL] [Abstract][Full Text] [Related]
5. Advances in melanoma therapy.
Johnson TM; Yahanda AM; Chang AE; Fader DJ; Sondak VK
J Am Acad Dermatol; 1998 May; 38(5 Pt 1):731-41. PubMed ID: 9591818
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant therapy for high-risk primary and resected metastatic melanoma.
Hersey P
Intern Med J; 2003; 33(1-2):33-43. PubMed ID: 12534876
[TBL] [Abstract][Full Text] [Related]
7. Approaches to regional nodes in patients with melanoma.
Deperalta DK; Hoang MP; Tanabe KK
J Clin Oncol; 2014 Mar; 32(9):881-5. PubMed ID: 24516017
[No Abstract] [Full Text] [Related]
8. Intermediate- and high-risk melanoma.
Agarwala SS
Curr Treat Options Oncol; 2002 Jun; 3(3):205-17. PubMed ID: 12057066
[TBL] [Abstract][Full Text] [Related]
9. [Melanoma].
Saida T
Gan To Kagaku Ryoho; 2006 Oct; 33(10):1386-91. PubMed ID: 17033225
[TBL] [Abstract][Full Text] [Related]
10. Lessons learned from the Sunbelt Melanoma Trial.
McMasters KM; Noyes RD; Reintgen DS; Goydos JS; Beitsch PD; Davidson BS; Sussman JJ; Gershenwald JE; Ross MI;
J Surg Oncol; 2004 Jul; 86(4):212-23. PubMed ID: 15221928
[TBL] [Abstract][Full Text] [Related]
11. The adjuvant treatment of malignant melanoma.
Reintgen D; Kirkwood J
J Fla Med Assoc; 1997 Mar; 84(3):147-52. PubMed ID: 9143164
[TBL] [Abstract][Full Text] [Related]
12. Effect of long-term adjuvant therapy with interferon alpha-2a in patients with regional node metastases from cutaneous melanoma: a randomised trial.
Cascinelli N; Belli F; MacKie RM; Santinami M; Bufalino R; Morabito A
Lancet; 2001 Sep; 358(9285):866-9. PubMed ID: 11567700
[TBL] [Abstract][Full Text] [Related]
13. Standards of care for patients with malignant melanoma.
Dunn CL; Zitelli JA
J Am Acad Dermatol; 2000 Jul; 43(1 Pt 1):155-8. PubMed ID: 10863245
[No Abstract] [Full Text] [Related]
14. Systemic adjuvant treatment of high-risk melanoma: the role of interferon alfa-2b and other immunotherapies.
Kirkwood JM
Eur J Cancer; 1998 Jul; 34 Suppl 3():S12-7. PubMed ID: 9849403
[TBL] [Abstract][Full Text] [Related]
15. The EORTC melanoma group translational research program on prognostic factors and ultrastaging in association with the adjuvant therapy trials in stage II and stage III melanoma. European Organization for Research and Treatment of Cancer.
Eggermont AM; Keilholz U; Testori A; Cook M; Lienard D; Ruiter DJ
Ann Surg Oncol; 2001 Oct; 8(9 Suppl):38S-40S. PubMed ID: 11599896
[TBL] [Abstract][Full Text] [Related]
16. Randomised trial of interferon alpha-2a as adjuvant therapy in resected primary melanoma thicker than 1.5 mm without clinically detectable node metastases. French Cooperative Group on Melanoma.
Grob JJ; Dreno B; de la Salmonière P; Delaunay M; Cupissol D; Guillot B; Souteyrand P; Sassolas B; Cesarini JP; Lionnet S; Lok C; Chastang C; Bonerandi JJ
Lancet; 1998 Jun; 351(9120):1905-10. PubMed ID: 9654256
[TBL] [Abstract][Full Text] [Related]
17. Use of adjuvant therapy in cutaneous melanoma.
Sondak VK
Expert Rev Anticancer Ther; 2001 Oct; 1(3):421-6. PubMed ID: 12113108
[TBL] [Abstract][Full Text] [Related]
18. [Interferon for adjuvant therapy in melanoma; although approved, not indicated].
Groenewegen G; Osanto S; van der Rhee HJ; Punt CJ
Ned Tijdschr Geneeskd; 2000 Nov; 144(45):2160-2. PubMed ID: 11086492
[TBL] [Abstract][Full Text] [Related]
19. Postsurgical adjuvant therapy for melanoma. Evaluation of a 3-year randomized trial with recombinant interferon-alpha after 3 and 5 years of follow-up.
Rusciani L; Petraglia S; Alotto M; Calvieri S; Vezzoni G
Cancer; 1997 Jun; 79(12):2354-60. PubMed ID: 9191523
[TBL] [Abstract][Full Text] [Related]
20. Sentinel-lymph-node biopsy.
Retsas S
N Engl J Med; 1999 Jan; 340(4):318-9. PubMed ID: 9935349
[No Abstract] [Full Text] [Related]
[Next] [New Search]
